| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae | 8 | 2022 | 178 | 3.460 |
Why?
|
| Saccharomyces cerevisiae Proteins | 7 | 2022 | 115 | 2.480 |
Why?
|
| Membrane Proteins | 11 | 2023 | 485 | 2.000 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 3 | 2018 | 15 | 1.230 |
Why?
|
| Membrane Transport Proteins | 2 | 2018 | 79 | 0.930 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 56 | 0.860 |
Why?
|
| Nucleic Acid Conformation | 7 | 2006 | 90 | 0.850 |
Why?
|
| Learning | 1 | 2025 | 100 | 0.840 |
Why?
|
| Metabolic Diseases | 1 | 2024 | 17 | 0.840 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2026 | 109 | 0.820 |
Why?
|
| Motivation | 1 | 2025 | 216 | 0.780 |
Why?
|
| Students | 1 | 2025 | 199 | 0.770 |
Why?
|
| Mitochondria | 2 | 2024 | 408 | 0.740 |
Why?
|
| Cell Membrane | 3 | 2025 | 268 | 0.730 |
Why?
|
| DNA | 6 | 2007 | 377 | 0.720 |
Why?
|
| Plasmids | 3 | 2017 | 126 | 0.660 |
Why?
|
| Shc Signaling Adaptor Proteins | 2 | 2022 | 8 | 0.650 |
Why?
|
| DNA, Cruciform | 4 | 2006 | 4 | 0.580 |
Why?
|
| Equilibrative Nucleoside Transport Proteins | 2 | 2018 | 2 | 0.580 |
Why?
|
| Recombinant Proteins | 4 | 2022 | 416 | 0.560 |
Why?
|
| Models, Molecular | 10 | 2007 | 452 | 0.560 |
Why?
|
| Equilibrative-Nucleoside Transporter 2 | 1 | 2017 | 1 | 0.550 |
Why?
|
| Vesicular Transport Proteins | 1 | 2017 | 34 | 0.530 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 3 | 2024 | 10 | 0.520 |
Why?
|
| Calcium | 1 | 2018 | 243 | 0.520 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2016 | 2 | 0.510 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2016 | 7 | 0.500 |
Why?
|
| Imatinib Mesylate | 1 | 2016 | 15 | 0.500 |
Why?
|
| Proteins | 1 | 2018 | 254 | 0.470 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 225 | 0.470 |
Why?
|
| Biophysical Phenomena | 2 | 2014 | 9 | 0.460 |
Why?
|
| Peptide Fragments | 1 | 2016 | 202 | 0.450 |
Why?
|
| src-Family Kinases | 1 | 2015 | 71 | 0.450 |
Why?
|
| Biochemistry | 1 | 2014 | 10 | 0.440 |
Why?
|
| Crystallography, X-Ray | 9 | 2009 | 222 | 0.440 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2014 | 45 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 344 | 0.420 |
Why?
|
| Humans | 18 | 2026 | 28851 | 0.390 |
Why?
|
| Signal Transduction | 2 | 2025 | 1469 | 0.390 |
Why?
|
| Animals | 14 | 2026 | 10684 | 0.380 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 686 | 0.330 |
Why?
|
| Protein Folding | 2 | 2022 | 47 | 0.300 |
Why?
|
| Endothelial Cells | 2 | 2025 | 373 | 0.280 |
Why?
|
| Oligonucleotides | 2 | 2005 | 27 | 0.280 |
Why?
|
| Drug Partial Agonism | 1 | 2007 | 2 | 0.280 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2007 | 2 | 0.280 |
Why?
|
| Tetraspanins | 2 | 2025 | 54 | 0.270 |
Why?
|
| Receptors, AMPA | 1 | 2007 | 8 | 0.270 |
Why?
|
| Protein Subunits | 1 | 2007 | 44 | 0.270 |
Why?
|
| Cloning, Molecular | 3 | 2017 | 208 | 0.270 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2006 | 31 | 0.260 |
Why?
|
| Histone Deacetylase 6 | 1 | 2026 | 8 | 0.240 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2026 | 30 | 0.240 |
Why?
|
| Solute Carrier Organic Anion Transporter Family Member 1B3 | 1 | 2026 | 21 | 0.240 |
Why?
|
| Lysine | 1 | 2026 | 78 | 0.230 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2025 | 28 | 0.230 |
Why?
|
| Base Sequence | 5 | 2014 | 588 | 0.230 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2025 | 65 | 0.220 |
Why?
|
| Capillary Permeability | 1 | 2025 | 56 | 0.220 |
Why?
|
| Gene Expression | 2 | 2017 | 417 | 0.220 |
Why?
|
| 2-Aminopurine | 1 | 2004 | 2 | 0.220 |
Why?
|
| Phosphorylation | 2 | 2016 | 585 | 0.220 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 64 | 0.220 |
Why?
|
| Forkhead Transcription Factors | 1 | 2024 | 35 | 0.210 |
Why?
|
| Cholesterol | 1 | 2025 | 203 | 0.210 |
Why?
|
| Kinetics | 2 | 2014 | 553 | 0.200 |
Why?
|
| Biological Transport | 2 | 2026 | 128 | 0.190 |
Why?
|
| Curriculum | 1 | 2025 | 303 | 0.190 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 163 | 0.190 |
Why?
|
| Antigens, CD | 1 | 2023 | 140 | 0.190 |
Why?
|
| Chromatography, Gel | 4 | 2017 | 38 | 0.190 |
Why?
|
| Glycosylation | 1 | 2022 | 70 | 0.180 |
Why?
|
| Protein Binding | 4 | 2018 | 667 | 0.180 |
Why?
|
| Mammals | 1 | 2022 | 48 | 0.180 |
Why?
|
| Protein Transport | 1 | 2022 | 158 | 0.180 |
Why?
|
| Chromatography, Affinity | 3 | 2017 | 32 | 0.170 |
Why?
|
| Neoplasms | 2 | 2023 | 874 | 0.170 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 292 | 0.160 |
Why?
|
| Escherichia coli | 2 | 2022 | 338 | 0.160 |
Why?
|
| Detergents | 2 | 2017 | 24 | 0.150 |
Why?
|
| Fermentation | 1 | 2019 | 52 | 0.150 |
Why?
|
| Type IV Secretion Systems | 1 | 2018 | 1 | 0.150 |
Why?
|
| Phagosomes | 1 | 2018 | 6 | 0.150 |
Why?
|
| Ehrlichia chaffeensis | 1 | 2018 | 4 | 0.150 |
Why?
|
| Solubility | 3 | 2014 | 73 | 0.140 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2018 | 30 | 0.140 |
Why?
|
| Endosomes | 1 | 2018 | 53 | 0.140 |
Why?
|
| Nucleosides | 1 | 2018 | 6 | 0.140 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 25 | 0.140 |
Why?
|
| Protein Conformation | 2 | 2008 | 258 | 0.130 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2017 | 2 | 0.130 |
Why?
|
| Crystallization | 2 | 2009 | 50 | 0.130 |
Why?
|
| Mutagenesis | 1 | 2016 | 46 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 36 | 0.130 |
Why?
|
| Allosteric Site | 1 | 2016 | 11 | 0.130 |
Why?
|
| src Homology Domains | 1 | 2016 | 31 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 72 | 0.120 |
Why?
|
| Protozoan Proteins | 1 | 2016 | 54 | 0.120 |
Why?
|
| Ligands | 1 | 2016 | 178 | 0.120 |
Why?
|
| Mitochondrial Membranes | 1 | 2015 | 20 | 0.120 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2015 | 37 | 0.120 |
Why?
|
| Deoxyribonucleotides | 2 | 2006 | 2 | 0.120 |
Why?
|
| Binding Sites | 1 | 2016 | 355 | 0.120 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2015 | 11 | 0.120 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2015 | 11 | 0.120 |
Why?
|
| Cell Line | 3 | 2018 | 700 | 0.120 |
Why?
|
| Solutions | 2 | 2006 | 31 | 0.120 |
Why?
|
| Protein Stability | 1 | 2015 | 43 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 137 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 44 | 0.120 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 62 | 0.110 |
Why?
|
| Protein Unfolding | 1 | 2014 | 1 | 0.110 |
Why?
|
| Ultracentrifugation | 1 | 2014 | 8 | 0.110 |
Why?
|
| Protein Denaturation | 1 | 2014 | 28 | 0.110 |
Why?
|
| Circular Dichroism | 1 | 2014 | 43 | 0.110 |
Why?
|
| Scattering, Radiation | 1 | 2014 | 29 | 0.110 |
Why?
|
| Hydrolysis | 1 | 2014 | 60 | 0.110 |
Why?
|
| Proteolipids | 1 | 2014 | 4 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 95 | 0.110 |
Why?
|
| Adenosine Triphosphatases | 1 | 2014 | 50 | 0.110 |
Why?
|
| DNA Primers | 1 | 2014 | 147 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 497 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 555 | 0.110 |
Why?
|
| Light | 1 | 2014 | 118 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 270 | 0.100 |
Why?
|
| Temperature | 1 | 2014 | 213 | 0.100 |
Why?
|
| Inflammation | 1 | 2017 | 667 | 0.090 |
Why?
|
| Genomics | 2 | 2009 | 124 | 0.090 |
Why?
|
| Transformation, Genetic | 1 | 2010 | 8 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2007 | 242 | 0.080 |
Why?
|
| Drug Resistance, Multiple | 1 | 2009 | 20 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2009 | 38 | 0.080 |
Why?
|
| Macromolecular Substances | 2 | 2007 | 53 | 0.080 |
Why?
|
| Genome, Human | 1 | 2009 | 70 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 85 | 0.080 |
Why?
|
| Databases, Protein | 1 | 2008 | 22 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2009 | 87 | 0.070 |
Why?
|
| Proteome | 1 | 2008 | 79 | 0.070 |
Why?
|
| Trichlormethiazide | 1 | 2007 | 1 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 1 | 2007 | 31 | 0.070 |
Why?
|
| Quinoxalines | 1 | 2007 | 17 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2007 | 62 | 0.070 |
Why?
|
| Pyramidal Cells | 1 | 2007 | 14 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 2007 | 10 | 0.070 |
Why?
|
| Hydrogen Bonding | 2 | 2007 | 39 | 0.070 |
Why?
|
| Cerebellum | 1 | 2007 | 41 | 0.070 |
Why?
|
| Interneurons | 1 | 2007 | 25 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 52 | 0.070 |
Why?
|
| Bromine | 1 | 2007 | 2 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 209 | 0.070 |
Why?
|
| Genetic Engineering | 1 | 2007 | 24 | 0.070 |
Why?
|
| Static Electricity | 2 | 2004 | 35 | 0.060 |
Why?
|
| Fractionation, Field Flow | 1 | 2006 | 1 | 0.060 |
Why?
|
| Hippocampus | 1 | 2007 | 198 | 0.060 |
Why?
|
| Anilides | 1 | 2026 | 24 | 0.060 |
Why?
|
| Acetylation | 1 | 2026 | 41 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2026 | 22 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2006 | 93 | 0.060 |
Why?
|
| Mice | 2 | 2023 | 4802 | 0.060 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2025 | 16 | 0.060 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2025 | 25 | 0.060 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2025 | 33 | 0.060 |
Why?
|
| Simvastatin | 1 | 2025 | 24 | 0.060 |
Why?
|
| Crystallography | 1 | 2005 | 6 | 0.060 |
Why?
|
| Hepatocytes | 1 | 2026 | 88 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2026 | 202 | 0.060 |
Why?
|
| Halogens | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cytosine | 1 | 2004 | 6 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2025 | 77 | 0.060 |
Why?
|
| Uridine | 1 | 2004 | 8 | 0.060 |
Why?
|
| Inosine | 1 | 2004 | 3 | 0.060 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 2004 | 9 | 0.060 |
Why?
|
| Base Pairing | 1 | 2004 | 25 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 128 | 0.050 |
Why?
|
| Proteomics | 1 | 2026 | 197 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2003 | 24 | 0.050 |
Why?
|
| Ions | 1 | 2003 | 19 | 0.050 |
Why?
|
| Pyrimidine Nucleotides | 1 | 2003 | 4 | 0.050 |
Why?
|
| Organophosphates | 1 | 2003 | 4 | 0.050 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2003 | 2 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2003 | 126 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 21 | 0.050 |
Why?
|
| Base Composition | 1 | 2003 | 110 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2023 | 34 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2025 | 874 | 0.050 |
Why?
|
| Melanoma | 1 | 2023 | 140 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 194 | 0.040 |
Why?
|
| Models, Biological | 1 | 2003 | 469 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 302 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 19 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2018 | 50 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2018 | 66 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2018 | 112 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 134 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 92 | 0.030 |
Why?
|
| Prealbumin | 1 | 2017 | 4 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 33 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 45 | 0.030 |
Why?
|
| Retinal Neurons | 1 | 2017 | 13 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 697 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 73 | 0.030 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2015 | 6 | 0.030 |
Why?
|
| Molecular Conformation | 2 | 2007 | 67 | 0.030 |
Why?
|
| Dimerization | 1 | 2015 | 76 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 68 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 1022 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 780 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1653 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2009 | 130 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2008 | 18 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 284 | 0.020 |
Why?
|
| Biophysics | 1 | 2007 | 14 | 0.020 |
Why?
|
| Uracil | 1 | 2007 | 10 | 0.020 |
Why?
|
| Male | 1 | 2023 | 13921 | 0.020 |
Why?
|
| Rotation | 1 | 2004 | 9 | 0.010 |
Why?
|
| Sus scrofa | 1 | 2003 | 12 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 277 | 0.010 |
Why?
|
| NAD | 1 | 2003 | 104 | 0.010 |
Why?
|